Forbes contributors publish independent expert analyses and insights. Anna Esaki-Smith is an author and covers higher education. By now, the stereotypes about Generation Z ring familiar: They’re ...

RMIT University researchers have developed a new way to coat fragile surfaces, including living plant leaves, using ...

There are all manner of musical synthesis techniques, from the early electromechanical instruments through analogue tape ...

In this post, we will show you how to create email templates in the new Outlook app for Windows 11. Creating email or message templates in Microsoft Outlook (classic) involved manually composing an ...

Jackie Allen, Jr., a third-generation farmer in Bardstown, Kentucky, leases two hundred and sixty acres near the Beech Fork River, and accepts that the family business ends with him. His progeny ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...

Generate:Biomedicines is hoping to raise up to $425 million via a Nasdaq IPO, with the proceeds needed to bankroll its lead antibody through respiratory disease trials. The Flagship Pioneering-founded ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...

Gen Z, this will smart. The generation born between 1997 and 2010 is the very first generation who did worse in school than the generation before them, according to a top neuroscientist. And ...